Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BRZE NASDAQ:NBIS NASDAQ:NICE NASDAQ:TEM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBRZEBraze$28.42-1.4%$31.63$25.22▼$48.33$3.00B1.11.31 million shs183,340 shsNBISNebius Group$46.17-2.0%$41.47$14.09▼$55.75$10.88B3.2511.21 million shs4.70 million shsNICENice$171.85-0.1%$166.13$137.19▼$200.65$10.86B1514,333 shs98,067 shsTEMTempus AI$58.26-0.4%$62.69$30.81▼$91.45$10.10BN/A7.43 million shs2.82 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBRZEBraze+1.44%+2.34%-3.03%-12.37%-25.70%NBISNebius Group-1.55%-6.38%-2.44%+100.77%+4,709,999,900.00%NICENice+1.46%+2.55%-2.67%+12.08%-1.00%TEMTempus AI+0.86%-1.56%-5.74%+33.61%+76.23%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBRZEBraze3.5568 of 5 stars4.52.00.00.01.83.30.6NBISNebius Group3.4568 of 5 stars4.70.00.00.03.90.00.6NICENice3.7098 of 5 stars3.32.00.00.03.81.72.5TEMTempus AI2.9807 of 5 stars3.34.00.00.02.02.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBRZEBraze 2.95Moderate Buy$46.3062.90% UpsideNBISNebius Group 3.33Buy$66.5044.03% UpsideNICENice 2.69Moderate Buy$209.7522.05% UpsideTEMTempus AI 2.50Moderate Buy$65.0911.73% UpsideCurrent Analyst Ratings BreakdownLatest BRZE, NBIS, TEM, and NICE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/30/2025TEMTempus AIGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$65.00 ➝ $75.006/25/2025TEMTempus AIBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$68.00 ➝ $70.006/24/2025BRZEBrazeOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$44.00 ➝ $38.006/20/2025NICENiceDA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$185.00 ➝ $195.006/20/2025NICENiceWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$200.006/18/2025NICENiceRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$200.006/18/2025NICENiceCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$161.006/18/2025NICENiceJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$300.006/18/2025NICENiceRosenblatt SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$190.006/16/2025NBISNebius GroupDA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$50.00 ➝ $55.006/13/2025NICENicePiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$153.00 ➝ $182.00(Data available from 7/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBRZEBraze$593.41M5.06N/AN/A$4.57 per share6.22NBISNebius Group$117.50M92.63N/AN/A$13.80 per share3.35NICENice$2.74B3.97$12.02 per share14.30$56.97 per share3.02TEMTempus AI$693.40M14.55N/AN/A$0.35 per share166.45Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBRZEBraze-$103.74M-$1.01N/AN/AN/A-16.76%-18.89%-10.26%9/4/2025 (Estimated)NBISNebius Group-$641.40M-$0.57N/AN/AN/AN/A-10.24%-9.69%7/29/2025 (Estimated)NICENice$442.59M$7.1723.9515.811.5416.77%16.37%11.15%8/13/2025 (Estimated)TEMTempus AI-$705.81M-$7.80N/AN/AN/A-88.27%-533.21%-66.19%8/5/2025 (Estimated)Latest BRZE, NBIS, TEM, and NICE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025TEMTempus AI-$0.23N/AN/AN/A$296.84 millionN/A7/29/2025Q2 2025NBISNebius Group-$0.41N/AN/AN/A$95.60 millionN/A6/5/2025Q1 2026BRZEBraze$0.05$0.07+$0.02-$0.34$158.60 million$162.06 million5/15/2025Q1 2025NICENice$2.84$2.87+$0.03$2.01$699.46 million$700.19 million5/6/2025Q1 2025TEMTempus AI-$0.27-$0.24+$0.03-$0.40$248.13 million$255.74 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBRZEBrazeN/AN/AN/AN/AN/ANBISNebius GroupN/AN/AN/AN/AN/ANICENiceN/AN/AN/AN/AN/ATEMTempus AIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBRZEBrazeN/A1.921.92NBISNebius GroupN/A18.0018.00NICENiceN/A1.601.60TEMTempus AI2.451.711.56Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBRZEBraze90.47%NBISNebius Group21.90%NICENice63.34%TEMTempus AI24.22%Insider OwnershipCompanyInsider OwnershipBRZEBraze18.20%NBISNebius GroupN/ANICENice0.02%TEMTempus AI27.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBRZEBraze1,699105.61 million86.39 millionOptionableNBISNebius Group1,371235.75 millionN/AN/ANICENice8,72663.25 million63.24 millionOptionableTEMTempus AI2,400173.12 million125.34 millionN/ABRZE, NBIS, TEM, and NICE HeadlinesRecent News About These CompaniesTEM Securities Lawsuit Filed Against Tempus AI, Inc. Contact the DJS Law Group to Discuss Your Rights2 hours ago | prnewswire.comVontobel Holding Ltd. Purchases New Holdings in Tempus AI, Inc. (NASDAQ:TEM)July 9 at 3:47 AM | marketbeat.comTEMPUS AI SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Tempus AI, Inc. - TEMJuly 8 at 10:16 PM | globenewswire.comHow AI Can Address the Troubled Business Model in OncologyJuly 8 at 9:55 PM | ajmc.comATEM Tempus AI, Inc.July 8 at 9:55 PM | seekingalpha.comPractical Considerations for AI in Community OncologyJuly 8 at 9:55 PM | ajmc.comATempus Expands AI-Enabled Care Pathway Intelligence Platform into Breast CancerJuly 8 at 9:55 PM | finance.yahoo.comTEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitJuly 8 at 4:00 PM | globenewswire.comTempus AI (NASDAQ:TEM) Trading Up 1% - Here's What HappenedJuly 8 at 2:41 PM | marketbeat.comCalamos Advisors LLC Acquires New Shares in Tempus AI, Inc. (NASDAQ:TEM)July 8 at 4:28 AM | marketbeat.comTeacher Retirement System of Texas Reduces Stock Holdings in Tempus AI, Inc. (NASDAQ:TEM)July 8 at 4:05 AM | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Tempus AI, Inc. of Class Action Lawsuit and Upcoming Deadlines - TEMJuly 7 at 3:00 PM | prnewswire.comTempus AI (NASDAQ:TEM) Shares Down 4.5% - Time to Sell?July 7 at 11:55 AM | marketbeat.comTEMPUS AI, INC. (NASDAQ: TEM) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Tempus AI, Inc. Investors of Upcoming DeadlineJuly 7 at 11:34 AM | globenewswire.comTempus AI Boosts R&D Efforts Through Wide-Ranging Product LaunchesJuly 7 at 10:55 AM | zacks.comAI in Medicine Hits Tipping Point as Investors Eye Next-Gen Healthcare PlatformsJuly 7 at 10:17 AM | baystreet.caTEM Securities Lawsuit Filed Against Tempus AI, Inc. Contact the DJS Law Group to Discuss Your RightsJuly 7 at 8:06 AM | prnewswire.comWealth Enhancement Advisory Services LLC Takes $440,000 Position in Tempus AI, Inc. (NASDAQ:TEM)July 7 at 3:14 AM | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Tempus AI, Inc. of Class Action Lawsuit and Upcoming Deadlines - TEMJuly 6 at 10:00 AM | globenewswire.comCambridge Investment Research Advisors Inc. Purchases Shares of 21,119 Tempus AI, Inc. (NASDAQ:TEM)July 6 at 3:28 AM | marketbeat.comWhy Tempus AI Stock Soared 15.2% in JuneJuly 5, 2025 | fool.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Notable Stocks Just Split: Which One Could Be the Big Winner?By Leo Miller | June 26, 2025View 3 Notable Stocks Just Split: Which One Could Be the Big Winner?Why Nebius Group Is One of the Top AI Stocks to WatchBy Thomas Hughes | June 17, 2025View Why Nebius Group Is One of the Top AI Stocks to WatchAeva & Mobileye: LiDAR Stocks Powering the Autonomous RevolutionBy Dan Schmidt | July 2, 2025View Aeva & Mobileye: LiDAR Stocks Powering the Autonomous RevolutionRocket Lab: Europe Comes Calling as Momentum BuildsBy Ryan Hasson | June 27, 2025View Rocket Lab: Europe Comes Calling as Momentum BuildsReddit Stock Ignites: Surge in Call Options Signals Big BetBy Gabriel Osorio-Mazilli | June 24, 2025View Reddit Stock Ignites: Surge in Call Options Signals Big BetBRZE, NBIS, TEM, and NICE Company DescriptionsBraze NASDAQ:BRZE$28.42 -0.41 (-1.42%) As of 11:36 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Braze, Inc. operates a customer engagement platform that provides interactions between consumers and brands worldwide. The company offers Braze software development kits that automatically manage data ingestion and deliver mobile and web notifications, in-application/in-browser interstitial messages, and content cards; REST API that can be used to import or export data or to trigger workflows between Braze and brands' existing technology stacks; Partner Data Integrations, which allow brands to sync user cohorts from partners; Data Transformation, in which brands can programmatically sync and transform user data; and Braze Cloud Data Ingestion that enables brands to harness their customer data. It also offers classification products, including segmentation that can define reusable segments of consumers based upon attributes, events, or predictive propensity scores; segment insights, which allows customers to analyze how segments are performing relative to each other across a set of pre-selected key performance indicators; and predictive suite that allows customers to identify groups of consumers that are of critical business value. In addition, the company provides Canvas, an orchestration tool that allows customers to create journeys, mapping out multi-steps, and cross-channel messaging experiences; campaigns, which allows customers to send one set of single-channel or multi-channel messages to be delivered to customers in a particular user segment; event and API triggering; marketing pressure management; and reporting and analytics. Further, it offers personalization products, such as liquid templating platform, connected content platform, content blocks, intelligent timing and channel, personalized variant, and AI item recommendations, and catalogs; and action products. The company was formerly known as Appboy, Inc. and changed its name to Braze, Inc. in November 2017. Braze, Inc. was incorporated in 2011 and is headquartered in New York, New York.Nebius Group NASDAQ:NBIS$46.17 -0.93 (-1.97%) As of 11:36 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Nebius Group N.V., a technology company, builds intelligent products and services powered by machine learning and other technologies to help consumers and businesses navigate the online and offline world. The company's services include Nebius AI, an AI-centric cloud platform that offers infrastructure and computing capability for AI deployment and machine-learning oriented solutions; and Toloka AI that offers generative AI (GenAI) solutions at every stage of the GenAI lifecycle, such as data annotation and generation, model training and fine-tuning, and quality assessment of large language model for accuracy and reliability. It also offers Avride, an autonomous driving solution which targets ride-hailing, logistics, e-commerce, and food/grocery delivery as application domains, as well as focuses on autonomous vehicles and delivery robots; and TripleTen, an EdTech service that prepares specialists for STEM roles, and equipping them with essential technology skills. The company was formerly known as Yandex N.V. and changed its name to Nebius Group N.V. in August 2024. Nebius Group N.V. was founded in 1989 and is based in Schiphol, the Netherlands.Nice NASDAQ:NICE$171.85 -0.13 (-0.08%) As of 11:36 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.NICE Ltd., together with its subsidiaries, provides cloud platforms for AI-driven digital business solutions worldwide. It offers CXone, a cloud native open platform; Enlighten, an AI engine for the customer engagement market; and smart self service enable organizations to address consumers' needs; and journey orchestration solutions that empower organizations to connect and route customers to deal with the customer's request, and connects them using real time AI-based routing. The company provides smart self service solutions that empower organizations to build intelligent automated conversations based on data; and prepared agent solutions and tools enable contact center agents to guide and alert them in real time; provides solutions that help organizations to record structured and unstructured customer interaction and transaction data; and NICE Evidencentral, an digital evidence management platform for public safety emergency communications, law enforcement, and criminal justice helps agencies. In addition, it offers X-Sight, is an open and flexible AI-cloud platform for financial crime and compliance; Xceed, a cloud platform for comprehensive AML and fraud prevention for small and mid-sized organizations; data intelligence solutions that enable organizations to turn raw data into comprehensive actionable intelligence to prevent and detect financial crimes; AI and analytics technologies to detect and prevent financial crimes in real-time; money laundering and fraud prevention solutions that help organizations adhere to capital markets compliance and anti-money laundering compliance regulations; intelligent investigations solutions; and self-service solutions that provide organizations with customization and self-development capabilities. The company was formerly known as NICE-Systems Ltd. and changed its name to NICE Ltd. in June 2016. NICE Ltd. was founded in 1986 and is headquartered in Ra'anana, Israel.Tempus AI NASDAQ:TEM$58.26 -0.25 (-0.43%) As of 11:36 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SoundHound Rises as Short Sellers Exit and AI Demand Grows Amazon's Prime Day Pullback Meets Bullish Golden Cross Signal Palantir’s Revenue Surge to $1B: Growth vs. Valuation Chime Financial: Analysts Ring In—And It’s a Buy Is Fortinet Ready to Break Out After Months of Consolidation? AST SpaceMobile: Is Market Noise Drowning Out a $100M Signal? CoreWeave's $9 Billion Power Play for Core Scientific Taiwan Semiconductor May Profit from Chinese Manufacturing Issues Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
